Shenzhen New Industries Biomedical Engineering : 9M profit rose 15.42%, while FX losses and logistics disruption weighed on overseas operations

What happened

Shenzhen New Industries Biomedical Engineering reported 9M revenue up 7.97% and net profit up 15.42%, with adjusted profit up 16.62%. Overseas core revenue rose 14.21%, but RMB appreciation caused ¥95.2m in FX losses and logistics disruption weighed on overseas operations.

Confirmed

Global impact / market context

RMB appreciation, which means the yuan strengthens against other currencies, reduced the value of overseas earnings, causing ¥95.2m in FX losses despite 14.21% overseas core revenue growth. Logistics disruption further weighed on overseas operations, showing currency and shipping costs can offset revenue gains and pressure profit.

Analyst inference

Investors may focus on whether overseas revenue growth can outweigh currency and logistics headwinds. Because overseas core revenue grew faster than total revenue, foreign sales are a key growth driver, so FX losses and logistics disruption directly affect profit and cash available for spending.

Analyst inference

What to watch

1. Watch whether RMB appreciation continues, since it already drove ¥95.2m in FX losses and reduced the value of overseas earnings when converted into yuan. Confirmed
2. Monitor management commentary on hedging or pricing actions to reduce currency exposure, which means steps to limit losses when exchange rates move against reported overseas earnings. Proposed
3. Track overseas revenue growth and logistics costs in future reports to see whether foreign sales still lift profit or whether FX and shipping costs keep offsetting gains. Analyst inference

Evidence

• Original source link unavailable